February 14, 2016
Recommended Topic Related To:

Azopt

"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...

A A A

Azopt




Indications
Dosage
How Supplied

INDICATIONS

AZOPT (brinzolamide ophthalmic suspension) 1% is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of AZOPT (brinzolamide ophthalmic suspension) 1% in the affected eye(s) three times daily. AZOPT (brinzolamide ophthalmic suspension) 1% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is used, the drugs should be administered at least ten (10) minutes apart.

HOW SUPPLIED

Dosage Forms And Strengths

Solution containing 10 mg/mL brinzolamide.

AZOPT (brinzolamide ophthalmic suspension) 1% is supplied in plastic DROP-TAINER† dispensers with a controlled dispensing-tip as follows:

10 mL NDC 0065-0275-10
15 mL NDC 0065-0275-15

Storage And Handling

Store AZOPT (brinzolamide ophthalmic suspension) 1% at 4-30°C (39-86°F). Shake well before use.

Distributed By: ALCON LABORATORIES, INC., Fort Worth, Texas 76134 USA. Revised: July 2015

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 11/23/2015

Indications
Dosage
How Supplied

Azopt - User Reviews

Azopt User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Azopt sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.